Approval to extend the expiration dating of reagents, calibrators, and controls to 14 months.  The device, as modified, will be marketed under the trade name architect anti-hcv and is indicated for the qualitative detection of immunoglobulin g (igg) and immunoglobulin m (igm) antibodies to hepatitis c virus (anti-hcv) in human adult and pediatric serum and plasma (potassium edta, lithium heparin, and sodium heparin).